SMAD2 and neoplasm: With a change in the immune microenvironment of the tumor dormancy site, or another unknown stimulation, activated tumor cells can convert to epithelial mesenchymal transition (EMT) through Smad2- and β-catenin-related signaling pathways and develop powerful invasiveness and rapid proliferation, penetrate vascular tissue, and even progress to distant metastasis.